Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.41 USD
Change Today -0.0164 / -3.85%
Volume 331.9K
CYTX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 12:34 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kenneth R. Chien M.D., Ph.D.

Scientific Advisor, Cytori Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 3 different organizations across 6 different industries.

See Board Relationships
----

Background*

Prof. Kenneth R. Chien, M.D., Ph.D, has been a Scientific Advisor of Cytori Therapeutics, Inc. (Formerly Macropore Biosurgery Inc). since June 8, 2005. He is Member of Scientific Advisory Board of Moderna Therapeutics, Inc. Dr. Chien serves as the Charles R. Sanders Endowed Chair in Medicine, of Harvard Medical School. He served as the Director of the Cardiovascular Research Center of Massachusetts General Hospital. He serves as the Chair of Cardiovascular Research of ...

Read Full Background

Corporate Headquarters*

3020 Callan Road
San Diego, California 92121

United States

Phone: 858-458-0900
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Temple University
MD
Temple University
BA
Harvard College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTX:US $0.41 USD -0.0164

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$599.8K
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
$789.5K
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
--
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$385.0K
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
$246.1K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTORI THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.